Post-Transplant Cyclophosphamide for Graft vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type: A Study from the Chronic Malignancies Working Party of the EBMT.
暂无分享,去创建一个
I. Yakoub-Agha | D. Blaise | S. Schönland | L. Castagna | J. Sanz | F. Ciceri | E. Forcade | E. Angelucci | E. Meijer | M. Rovira | Y. Koç | P. Hayden | J. Tischer | D. Valcárcel | F. Stölzel | L. Koster | F. Sahebi | A. Mcdonald | N. Kroger | D. Eikema | A. Proia | J. V. van Doesum | S. Sammassimo | M. Beksaç | C. H. Arroyo | James F. Sanchez | James F. Sanchez | Y. Koc